Skip to content
Screener

Ginkgo Bioworks DNA Total Current Assets

Total Current Assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$23.37B-5.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.53B+4.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$679.23M-8.5%
eXoZymes, Inc. logo
eXoZymes, Inc.EXOZ
$2.09M-77.8%
TEC
Bio-TechneTECH
$688.05M+9.7%
Revvity logo
RevvityRVTY
$2.3B+2.8%

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.0%
Enterprise value$752.73M-14.6%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054298
Line itemAs of June 30, 2026As of December 31, 2025
Accounts receivable, net13,01324,026
Accounts receivable - related parties229
Prepaid expenses and other current assets (includes $4,444 and zero from related parties)17,35924,963
Total current assets332,535471,838
Restricted cash and cash equivalents, non-current84,56538,138
Property, plant and equipment, net157,185167,371
Operating lease right-of-use assets347,661360,918
Investments14,77515,066

Item 1. Financial Statements (Unaudited)

FAQ

What is Ginkgo Bioworks's total current assets?
Ginkgo Bioworks (DNA) reported total current assets of $332.54M in Q2 2026.
How has Ginkgo Bioworks's total current assets changed year-over-year?
Ginkgo Bioworks's total current assets decreased by 36.4% year-over-year, from $523.03M to $332.54M.
What is the long-term trend for Ginkgo Bioworks's total current assets?
Over 5 years (2020 to 2025), Ginkgo Bioworks's total current assets has grown at a 2.0% compound annual growth rate (CAGR), from $426.54M to $471.84M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Ginkgo Bioworks's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude